did serena williams really use glp-1 and the coming reckoning with GLP-1s and performance enhancement Serena Williams Opens Up About

The stall reflects a new equilibrium between these pharmaceutical effects and your body counterregulatory forces

Some people are arguing that the weight loss itself and the lack of eating can, in some people who are vulnerable, induce a low mood and perhaps suicidal thinking

E.Hubbard-LuceyV

release of neurotransmitters, cell-to-cell signalling, cell adhesions, apoptosis, ionic transportation, enzyme regulation as well as protein covalent modifications, such as folding and maturation

While a formal ethics committee review and documentation were not conducted, the research was carried out in accordance with ethical principles aimed at protecting participant rights and ensuring privacy

Clinical trials with GLP-1 receptor agonists consistently demonstrate significant weight loss, with higher doses (such as semaglutide 2.4 mg weekly) producing approximately 15% average weight loss in adults without diabetes in clinical trials (somewhat less in type 2 diabetes) when combined with lifestyle modification